Cone Morse Implant Placement in Patients With Aids Who Use Highly Active Antiretroviral Therapy Report of Clinical Cases

Resumo (EN)

Introduction:
The Acquired Immune Deficiency Syndrome (AIDS) is a condition that manifests itself after the infection of the human organism by the Human
Immunodeficiency Virus (HIV). In 1996, the Highly Active Antiretroviral Therapy (HAART) was introduced, with the aim of slowing down the
immunodeficiency and restoring the immunity of these patients, extending their life expectancy. Consequently, the need for rehabilitating dental
treatments arose, aiming to improve oral health, self-esteem and the quality of life of these patients. This current study was designed to assess
vertical dimensional changes in the peri-implant bone level around the placement of dental implants in AIDS patients using HAART.
Materials and Methods:
For the bone level evaluation, at first cone-beam computed tomography, panoramic radiography and periapical radiographs were used during the
periods at baseline, 2, 4 and 6 months after the implant installation. The images were digitized and analyzed on programs Adobe Photoshop CS5
and Digimizer 3.1.1.0.
Results:
Were installed 13 implants that presented a peri-implant bone loss average of 0.26 mm in the first bimester, 0.13 mm in the second and 0.18 mm in
the third, totalizing a peri-implant bone loss average of 0.57 mm in the semester.
Conclusion:
Despite the several metabolic changes that can affect these patients due to infection, drug therapy, immune response and the absence of an
adequate stability quotient and insertion torque, all implants showed osseointegration, as well as the parameters of clinical success after the
installation of the implant, and the degree of bone loss in this period is within the expected according to the research.
Clinical Relevance:
Oral health professionals should be aware of the possible complications that future HIV patients may have due to their systemic and drug-related
condition in association with osseointegration.
Materiais e métodos:
Para a avaliação do nível ósseo, primeiramente foram utilizadas tomografia computadorizada cone-beam, radiografia panorâmica e radiografias periapicais durante os períodos basal, 2, 4 e 6 meses após a instalação do implante. As imagens foram digitalizadas e analisadas nos programas Adobe Photoshop CS5 e Digimizer 3.1.1.0.

Resultados:
Foram instalados 13 implantes que apresentaram perda óssea peri-implantar média de 0,26 mm no primeiro bimestre, 0,13 mm no segundo e 0,18 mm no terceiro, totalizando uma perda óssea peri-implantar média de 0,57 mm no semestre.

Conclusão:
Apesar das diversas alterações metabólicas que podem acometer esses pacientes devido à infecção, terapia medicamentosa, resposta imune e ausência de quociente de estabilidade e torque de inserção adequados, todos os implantes apresentaram osseointegração, bem como os parâmetros de sucesso clínico após a instalação do implante, e o grau de perda óssea nesse período está dentro do esperado segundo a pesquisa.